Immunocompromised individuals face ongoing COVID-19 risks despite vaccination, highlighting the need for tailored public health strategies and innovative therapies.
Jade Gambill, BS
Advertisement
Articles by Jade Gambill, BS
Several lymphoma experts discuss the current T-cell lymphoma landscape, the need for new therapies, and ongoing research in the space.
Advertisement
Latest Updated Articles
Safeguarding Vulnerability: COVID-19’s Impact on Immunocompromised Patients With CancerPublished: August 15th 2025 | Updated:
Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment StrategiesPublished: March 7th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Advises Against BLA for Novel Vaccine Combo/Pembrolizumab in Melanoma
2
Moving Beyond Chemotherapy in Relapsed/Refractory ES-SCLC Treatment
3
TTFields After SRS Prolongs Intracranial Response in Brain Metastatic NSCLC
4
Treatment Decision-Making in Multiple Myeloma at First and Subsequent Relapses
5
